Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2026 09:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Respiratory Syncytial Virus (RSV) Vaccines Market to Reach $1.24 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The global Respiratory Syncytial Virus (RSV) vaccines market is entering a critical phase of maturation and strategic realignment, with valuation...
February 17, 2026 23:00 ET | Source: Bio Usawa Inc

Defeating the "Cold Chain" Barrier: Bio Usawa and Nanoly Bioscience Announce Strategic $500 Million Licensing Agreement for Breakthrough DynaShield™ Technology

SAN FRANCISCO and LOS ANGELES and KIGALI, Rwanda, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical...
January 28, 2026 08:32 ET | Source: Visiongain

Vaccine Contract Manufacturing Market to Reach US$11,065.6 Million by 2036, as Immunisation Expansion and Rising Manufacturing Complexity Drive Outsourcing

The global Vaccine Contract Manufacturing market is projected to grow at a CAGR of 10.9% by 2036 and reach US$11,065.6 million by 2036.
January 27, 2026 14:29 ET | Source: Association of American Physicians and Surgeons

The Association of American Physicians and Surgeons (AAPS) Supports ACIP Vaccine Panel Chairman, Kirk Milhoan, M.D.

Vaccine panel chairman, pediatric cardiologist Kirk Milhoan, M.D., is on solid ground scientifically and ethically, state physicians, in requiring consent
January 19, 2026 06:44 ET | Source: Research and Markets

Aquaculture Vaccine Market Set to Nearly Double by 2033, Driven by Rising Disease Prevention Efforts

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product (Attenuated Live Vaccines, Inactivated Vaccines), Route of...
January 14, 2026 13:14 ET | Source: Asthma and Allergy Foundation of America

Amid COVID-19 Vaccine Confusion, New Tool Helps Guide Decision-Making

Washington, DC, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces the release of a new COVID-19 Vaccine Decision Aid, designed to help people...
January 14, 2026 08:00 ET | Source: Unity Consortium

Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule

Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
January 08, 2026 16:34 ET | Source: Asthma and Allergy Foundation of America

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

Washington, DC, Jan. 08, 2026 (GLOBE NEWSWIRE) -- On January 5, 2026, under Health and Human Services Secretary Kennedy’s leadership, the Centers for Disease Control and Prevention (CDC) released...
January 08, 2026 16:05 ET | Source: Asthma and Allergy Foundation of America

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

Washington, DC, Jan. 08, 2026 (GLOBE NEWSWIRE) -- On January 5, 2026, under Health and Human Services Secretary Kennedy’s leadership, the Centers for Disease Control and Prevention (CDC) released...
January 07, 2026 08:01 ET | Source: Vaxxas Pty Ltd

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive...